Adam M. Veness, SVP, General Counsel and Sec: Dianthus Therapeutics DNTH Sell · Filed 06/18

Trade details

Type: Insider sale
Amount: $1,347,382.14
Shares · price: 16,771 sh · $80.34 a share
Held after: 13,229 sh
Stock: Dianthus Therapeutics DNTH
Person: Adam M. VenessSVP, General Counsel and Sec
Trade date: 26/06/17
Filed: 26/06/18
Days to filing: 1 days

Sold 55.9% of holdings

Share of holding sold: 55.9%

Dianthus Therapeutics trades, last 26 weeks

What else happened in Dianthus Therapeutics around then

Filed or reported within 30 days of the trade day · 05/18~07/17

Adam M. Veness's recent trades

Adam M. VenessSVP, General Counsel and Sec
Planned sale10b5-1 planDianthus Therapeutics
Planned sale10b5-1 plan
Dianthus Therapeutics
DNTH
$1.8M
16,167 sh
$1.8M
Filed 08/10
Traded 08/10
Adam M. VenessSVP, General Counsel and Sec
Planned sale10b5-1 planDianthus Therapeutics
Planned sale10b5-1 plan
Dianthus Therapeutics
DNTH
$421.3K
3,833 sh
$421.3K
Filed 08/07
Traded 08/07
Adam M. VenessSVP, General Counsel and Sec
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$1.1M
13,229 sh
$1.1M
Filed 06/18
Traded 06/17
Adam M. VenessSVP, General Counsel and Sec
Planned sale10b5-1 planDianthus Therapeutics
Planned sale10b5-1 plan
Dianthus Therapeutics
DNTH
$2.4M
30,000 sh
$2.4M
Filed 06/17
Traded 06/17